Matthews International: DBE Narrative Cannot Mask A Broken Operating Quarter, Maintain Sell

Matthews International (NASDAQ: MATW) collapsed 14.3% to $23.70 today as its fiscal Q3 2026 earnings disaster confirmed what the balance sheet already screamed. The stock is not a bargain. It is a company with a 4.3% dividend, negative cash flow, a CEO stepping down, and a dry battery electrode (DBE) story that won't contribute revenue until the second half of fiscal 2027. I maintain my Sell rating.

The quarter that broke the case

Revenue fell 29.6% year-over-year to $246.02 million, missing estimates by roughly $28 million. Adjusted EPS came in at $0.06 against a $0.38 consensus — an 84% miss. On a GAAP basis, Matthews posted a net loss of $23.7 million, compared to $15.4 million in net income a year ago. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization — a rough proxy for operating cash generation) declined 21.5% to $35 million from $44.6 million. Management then cut full-year adjusted EBITDA guidance to $158 million–$162 million, down from the prior $180 million–$190 million range.

This is not a stock that reset to a cheaper multiple while the business held together. The business deteriorated, and the stock is only beginning to price it in.

DBE: strong interest, zero revenue, massive cost

The DBE offering — Matthews' proprietary dry battery electrode manufacturing technology, which eliminates solvents from lithium-ion battery production — is the centerpiece of the bullish case. Management described customer interest as "the most significant we have ever seen," noting that OEMs and battery suppliers including LG and Samsung, plus major European, Japanese, and Korean automakers, have reserved testing time on Matthews' mass production machine starting in October.

The problem is timing. Management itself said meaningful DBE revenue will not arrive until the second half of fiscal 2027. That is 12 months out. In the meantime, the DBE business is a line-item drain. The Industrial Technologies segment — which houses DBE — reported an adjusted EBITDA loss of $5.4 million in Q3, down from $9.0 million of profitability a year ago. The ongoing Tesla arbitration has generated $7.8 million in litigation costs this quarter alone and $18.9 million year-to-date. The arbitrator ruled in Matthews' favor in February, confirming the company's right to sell DBE equipment to third parties, but that legal clarity has not yet translated into bookings.

This is the textbook unfunded narrative I distrust. AI pivots, technology platforms, and battery manufacturing stories are not investable when the revenue clock runs 12 months forward while the cost clock runs today. The DBE thesis may be legitimate in concept — dry electrode processing could matter for next-generation solid-state and sodium batteries — but Matthews is paying for the privilege of proving it with real cash on a balance sheet that has $567 million of gross debt and only $37.6 million of cash.

The segments that actually produce cash are under pressure

Memorialization — the casket and cemetery business — remains the company's anchor. Revenue grew 2.1% to $208.1 million, but adjusted EBITDA slipped to $42.2 million from $42.8 million. The margin compression came from record-low U.S. death rates (declining roughly 4.6% annually) and input costs that outpaced price increases. Copper jumped from $4.50 to $6.60 per pound; steel costs rose 21% year-over-year. Management noted customers are migrating toward lower-priced products. The segment still targets $175 million in full-year adjusted EBITDA, which would be a record, but that projection assumes Q4 seasonal strength arrives without further margin erosion.

Product Identification (barcoding and printing equipment) grew 5% to $24 million, supported by the Axian printhead technology and a new partnership with Linx Printing Technologies for the U.K. and France markets. That is a genuine bright spot, but $24 million of revenue cannot carry a $1.28 billion enterprise value.

The European engineering operation is being restructured to cut $10 million in annual costs, with strategic alternatives under review. Management expects improvement in fiscal 2027, though German labor regulations may delay savings. This is a business unit that posted $14 million in engineering revenue and is now being put up for potential sale.

The dividend is not support — it is a liability

MATW pays a quarterly dividend of $0.255 per share, yielding 4.3%. The company has paid dividends for 16 consecutive years, which sounds like a comfort feature until you check the math. Free cash flow over the trailing twelve months was negative $81.97 million. Operating cash flow for the first nine months of fiscal 2026 was negative $69.5 million. The dividend payout ratio sits at 329% — the company is paying out more than three dollars in dividends for every dollar of earnings.

Dividend yield traps are my default distrust category. The yield only works if the balance sheet and cash flow can honor it. With net debt of $530 million and free cash flow in deeply negative territory, this dividend is funded by debt capacity and hope. If the bank covenants tighten or the Propelis JV underperforms further, that 4.3% yield gets cut — and the stock drops harder.

Valuation tells the same story

At $23.70, Matthews trades at 76 times trailing earnings and an absurd 185 times forward earnings. The enterprise value of $1.28 billion on a $740 million market cap reflects $530 million of net debt sitting behind the stock price. The EV/EBITDA multiple of 9.1x on a trailing basis looks more defensible on its face, but it is built on a $160 million adjusted EBITDA outlook that management just cut by roughly $20 million and a business whose revenue declined 33% year-to-date.

Wall Street Zen downgraded the stock from Hold to Sell today. Weiss Ratings maintains a Sell rating. The consensus has moved to Reduce. When three independent research sources converge on Sell after a quarter like this, the market is not mispricing fear — it is pricing reality.

The CEO retirement adds a structural risk

Joe Bartolacci, who has led Matthews for 20 years, announced his retirement on August 4th. He will stay through at least January 1, 2027, to oversee a transition. Succession planning during an earnings miss, a guidance cut, a negative-cash-flow environment, and a segment under strategic review is not the ideal timing. Investors do not get to separate the founder's narrative around DBE from the execution that will follow his departure.

What would change the rating

I would move toward Hold if DBE booking evidence materializes before the end of fiscal 2026 — actual signed contracts, not reserved testing slots. I would look at a Buy case only if the stock falls well below $20, Memorialization delivers on the $175 million EBITDA target, and free cash flow turns positive before the dividend comes under threat. Until then, the DBE story is a promise, the cash flow is negative, the dividend is overstretched, and the CEO is leaving.

Maintain Sell. The valuation has not reset enough to offset the operating deterioration. Step aside.